Scott Bizily, Chief Legal Officer of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) FDMT (NASDAQ:FDMT) , disclosed in a Form 4 filed on August 17, 2026, that he completed two rounds of stock option …
4D Molecular Therapeutics CLO Scott Bizily Executes Stock Option Exercises and Sales Under 10b5-1 Plan
view original post